Vitamin D Research Today is a free monthly online journal that collates and summarizes the latest research about Vitamin D, including details on sources, melanin, benefits, deficiency, supplements, calcium absorption.

Volume 4 (2007), Issue 4 (April)

1. Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease.
   Am J Cardiol, 99(7): 903-5. [Abstract] [Full-text]
2. Picking a bone with contemporary osteoporosis management: nutrient strategies to enhance skeletal integrity.
   Clin Nutr, 26(2): 193-207. [Abstract] [Full-text]
3. Vitamin D fortification of milk products does not resolve hypovitaminosis D in young Finnish men.
   Eur J Clin Nutr, 61(4): 493-7. [Abstract] [Full-text]
4. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.
   Cancer Epidemiol Biomarkers Prev, 16(4): 783-8. [Abstract] [Full-text]
5. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
   J Biol Chem, 282(15): 10953-62. [Abstract] [Full-text]
6. Klotho: an antiaging protein involved in mineral and vitamin D metabolism.
   Kidney Int, 71(8): 730-7. [Abstract] [Full-text]
7. 1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells.
   Mol Cancer Ther, 6(4): 1433-9. [Abstract] [Full-text]
8. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury.
   BMC Immunol, 8: 5. [Abstract] [Full-text]
9. The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis.
   QJM, 100(4): 185-92. [Abstract] [Full-text]
10. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension.
    Hypertension, 49(5): 1063-9. [Abstract] [Full-text]
11. Serum 25-OHD insufficiency as a risk factor for hip fracture.
    J Bone Miner Metab, 25(3): 147-50. [Abstract] [Full-text]
12. Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.
    J Bone Miner Res, 22(5): 686-94. [Abstract] [Full-text]
13. Seasonal change in osteoid thickness and mineralization lag time in ambulant patients.
    J Bone Miner Res, 22(5): 757-61. [Abstract] [Full-text]
14. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease.
    Clin Gastroenterol Hepatol, 5(4): 513-20. [Abstract] [Full-text]
15. Smoothing the mosaic subclinical melanoderma by calcipotriol.
    J Eur Acad Dermatol Venereol, 21(5): 657-61. [Abstract] [Full-text]
16. 1,25-dihydroxyvitamin D3 induces biphasic NF-kappaB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IkappaB.
    Exp Cell Res, 313(8): 1722-34. [Abstract] [Full-text]
17. Bioavailability of seocalcitol III. Administration of lipid-based formulations to minipigs in the fasted and fed state.
    Eur J Pharm Sci, 31(1): 8-15. [Abstract] [Full-text]
18. Vitamin D receptor-mediated suppression of RelB in antigen presenting cells: a paradigm for ligand-augmented negative transcriptional regulation.
    Arch Biochem Biophys, 460(2): 218-26. [Abstract] [Full-text]
19. Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol.
    Arch Biochem Biophys, 460(2): 172-6. [Abstract] [Full-text]
20. An architectural perspective of vitamin D responsiveness.
    Arch Biochem Biophys, 460(2): 293-9. [Abstract] [Full-text]
21. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function.
    Arch Biochem Biophys, 460(2): 202-5. [Abstract] [Full-text]
22. 2-Methylene-19-nor-1alpha-hydroxyvitamin D3 analogs inhibit adipocyte differentiation and PPARgamma2 gene transcription.
    Arch Biochem Biophys, 460(2): 192-201. [Abstract] [Full-text]
23. Factors that influence the cutaneous synthesis and dietary sources of vitamin D.
    Arch Biochem Biophys, 460(2): 213-7. [Abstract] [Full-text]
24. New analogs of 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 with conformationally restricted side chains: evaluation of biological activity and structural determination of VDR-bound conformations.
    Arch Biochem Biophys, 460(2): 161-5. [Abstract] [Full-text]
25. Vitamin D receptor expression by the lung micro-environment is required for maximal induction of lung inflammation.
    Arch Biochem Biophys, 460(2): 306-13. [Abstract] [Full-text]
26. Calbindin D9k is not required for 1,25-dihydroxyvitamin D3-mediated Ca2+ absorption in small intestine.
    Arch Biochem Biophys, 460(2): 227-32. [Abstract] [Full-text]
27. Duodenal calcium absorption in dexamethasone-treated mice: functional and molecular aspects.
    Arch Biochem Biophys, 460(2): 300-5. [Abstract] [Full-text]
28. Generation of a homology model for the human cytochrome P450, CYP24A1, and the testing of putative substrate binding residues by site-directed mutagenesis and enzyme activity studies.
    Arch Biochem Biophys, 460(2): 177-91. [Abstract] [Full-text]
29. Identification of a highly potent vitamin D receptor antagonist: (25S)-26-adamantyl-25-hydroxy-2-methylene-22,23-didehydro-19,27-dinor-20-epi-vitamin D3 (ADMI3).
    Arch Biochem Biophys, 460(2): 240-53. [Abstract] [Full-text]
30. Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the Vitamin D pathway: insights into substrate specificity and membrane bound structure-function.
    Arch Biochem Biophys, 460(2): 262-73. [Abstract] [Full-text]
31. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
    Arch Biochem Biophys, 460(2): 254-61. [Abstract] [Full-text]
32. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory.
    Diabetes Res Clin Pract, 77(1): 47-57. [Abstract] [Full-text]
33. Methyl substitution of the 25-hydroxy group on 2-methylene-19-nor-1alpha,25-dihydroxyvitamin D3 (2MD) reduces potency but allows bone selectivity.
    Arch Biochem Biophys, 460(2): 274-84. [Abstract] [Full-text]
34. Mechanism of vitamin D3-induced transcription of phospholipase D1 in HaCat human keratinocytes.
    FEBS Lett, 581(9): 1800-4. [Abstract] [Full-text]
35. Calcitriol is a potent inhibitor of retinal neovascularization.
    Invest Ophthalmol Vis Sci, 48(5): 2327-34. [Abstract] [Full-text]
36. Vitamin D3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators.
    Mol Pharmacol, 71(5): 1298-311. [Abstract] [Full-text]
37. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
    Carcinogenesis, 28(5): 1000-7. [Abstract] [Full-text]
38. Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women.
    Am J Epidemiol, 165(10): 1178-86. [Abstract] [Full-text]

© 2004-2008 Vitamin D Research Today. All Rights Reserved.